These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16540653)

  • 1. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
    Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.
    Mariano AR; Colombo E; Luzi L; Martinelli P; Volorio S; Bernard L; Meani N; Bergomas R; Alcalay M; Pelicci PG
    Oncogene; 2006 Jul; 25(31):4376-80. PubMed ID: 16501600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
    Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
    N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
    Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
    Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
    Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP
    Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.
    Bolli N; Nicoletti I; De Marco MF; Bigerna B; Pucciarini A; Mannucci R; Martelli MP; Liso A; Mecucci C; Fabbiano F; Martelli MF; Henderson BR; Falini B
    Cancer Res; 2007 Jul; 67(13):6230-7. PubMed ID: 17616680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
    Moulin S; Llanos S; Kim SH; Peters G
    Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
    Bertwistle D; Sugimoto M; Sherr CJ
    Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network.
    Castelli M; Pieroni S; Brunacci C; Piobbico D; Bartoli D; Bellet MM; Colombo E; Pelicci PG; Della Fazia MA; Servillo G
    Oncogene; 2013 Jul; 32(28):3350-8. PubMed ID: 22890319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nucleophosmin in acute myeloid leukemia.
    Meani N; Alcalay M
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution.
    Chou WC; Tang JL; Lin LI; Yao M; Tsay W; Chen CY; Wu SJ; Huang CF; Chiou RJ; Tseng MH; Lin DT; Lin KH; Chen YC; Tien HF
    Cancer Res; 2006 Mar; 66(6):3310-6. PubMed ID: 16540685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
    Li J; Zhang X; Sejas DP; Pang Q
    Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death.
    Reef S; Zalckvar E; Shifman O; Bialik S; Sabanay H; Oren M; Kimchi A
    Mol Cell; 2006 May; 22(4):463-75. PubMed ID: 16713577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
    Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
    Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
    Chen D; Yoon JB; Gu W
    Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ARF tumour suppressor.
    Gallagher SJ; Kefford RF; Rizos H
    Int J Biochem Cell Biol; 2006; 38(10):1637-41. PubMed ID: 16600663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
    Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD
    Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.